Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$163,688,742
-$16,421,493 QoQ
Shares Held
644,520
-12.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#233
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. JNJ ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,217,590 | $588,737,534 | |
| 2 | LLY |
ELI LILLY & Co
|
344,960 | $413,755,406 | |
| 3 | PFE |
Pfizer Inc
|
16,584,797 | $399,361,911 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,370,439 | $176,101,411 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
644,520 | $163,688,742 | |
| 6 | AZN |
Astrazeneca PLC
|
558,835 | $105,966,291 | |
| 7 | NVS |
Novartis AG
|
633,523 | $99,285,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
716,459 | $90,517,428 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $163,688,742 | 644,520 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $180,110,235 | 736,828 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $155,995,184 | 753,782 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $114,011,419 | 614,882 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $131,603,137 | 861,559 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $126,969,093 | 765,612 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $115,466,632 | 798,414 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $126,436,942 | 780,186 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $101,154,266 | 692,079 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $105,099,378 | 664,387 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $92,400,737 | 589,516 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $86,222,420 | 553,595 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $86,686,795 | 523,724 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $88,611,485 | 571,687 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $113,331,573 | 641,560 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $115,807,047 | 708,907 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $102,664,328 | 578,358 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $88,769,012 | 500,869 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $80,759,238 | 472,083 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $67,319,659 | 416,840 | Shares | Defined | 2021-11-03 | |
| 2021-06-30 | $58,389,621 | 354,435 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $55,572,157 | 338,133 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $45,994,934 | 292,254 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $39,615,627 | 266,091 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $33,037,502 | 234,925 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $26,074,020 | 198,841 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||